Track Real Time Price

According to ChemAnalyst , The global Furosemide Prices moved upward during the second quarter of 2026, reflecting a combination of higher producer input costs, changing pharmaceutical demand, feedstock volatility, and regional supply-chain conditions. Furosemide, a widely used loop diuretic, remains an important active pharmaceutical ingredient (API) for the production of medicines used to manage fluid retention associated with conditions such as heart failure, liver disease, and certain kidney disorders. During Q2 2026, price movements varied across major regional markets. In APAC , higher producer costs supported an increase in the Furosemide Price Index, while stable industrial activity helped maintain supply availability. In North America , stronger producer inflation and tighter global chemical supply conditions contributed to higher pricing. Meanwhile, the European market also experienced upward price pressure as energy, naphtha, and intermediate costs increased, particularly i...

According to ChemAnalyst , The Furosemide Prices trend remained on an upward trajectory across major global markets during the second quarter of 2026. Rising manufacturing expenses, increasing producer input costs, firm feedstock prices, and resilient pharmaceutical demand supported price growth in Asia-Pacific (APAC), North America, and Europe. Despite varying macroeconomic conditions across regions, the global Furosemide market benefited from stable healthcare demand, ongoing pharmaceutical production, and supply-side cost pressures. Furosemide, one of the world's most widely prescribed loop diuretics, is extensively used for the treatment of edema associated with heart failure, liver disease, kidney disorders, and hypertension. Because it is considered an essential medicine, demand generally remains resilient even during periods of economic uncertainty. However, fluctuations in raw material costs, energy prices, transportation expenses, and pharmaceutical manufacturing economic...